Impact of concomitant nontuberculous mycobacteria and <em>Pseudomonas aeruginosa</em> isolates in non-cystic fibrosis bronchiectasis

Abstract

Concomitant NTM and <i>P. aeruginosa</i> isolates in non-CF bronchiectasis are associated with the greatest pulmonary function decline and the worst disease severity. This result suggested that early recognition and prompt treatment of concomitant NTM and <i>P. aeruginosa</i> isolates may improve the outcome in non-CF bronchiectasis patients.